Evidence map›Paper›PMID 38832777›Full record

ArticlemBio2024

The N-terminus of the

Anna Vincek, Anja Wolf, Astrid Thomas, Frank Ebel, Sebastian Schruefer

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna VincekInstitute for Infectious Diseases and Zoonoses, LMU Munich, Germany.
Anja WolfInstitute for Infectious Diseases and Zoonoses, LMU Munich, Germany.
Astrid ThomasInstitute for Infectious Diseases and Zoonoses, LMU Munich, Germany.
Frank EbelInstitute for Infectious Diseases and Zoonoses, LMU Munich, Germany.ORCID 0000-0002-1027-1440
Sebastian SchrueferInstitute for Infectious Diseases and Zoonoses, LMU Munich, Germany.ORCID 0000-0002-8542-1300

Funding

Deutsche Forschungsgemeinschaft (DFG) EB184/8-1
6 · The paper itself

Abstract

Group III hybrid histidine kinases are fungal-specific proteins and part of the multistep phosphorelay, representing the initial part of the high osmolarity glycerol (HOG) pathway. TcsC, the corresponding kinase in IMPORTANCE: Signaling pathways enable pathogens, such as

Indexed as

Aspergillus fumigatusCell NucleusDioxolesFungal ProteinsHistidine KinasePyrrolesAntifungal AgentsCytoplasmGene Expression Regulation, FungalOsmolar ConcentrationOsmotic PressureProtein TransportSignal TransductionAntifungal AgentsDioxolesfludioxonilFungal ProteinsHistidine KinasePyrrolesAspergillus fumigatusgroup III hybrid histidine kinaseHOG pathwaynuclear localization sequenceSakATcsCYpd1

Identifiers

PMID38832777
PMCPMC11253588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.